Showing results (881-890 of 3,708) with videos related to

Sort By:
Pageof 371
Neurorehabilitation and Neural Repair|October 30, 2015
Compensatory Versus Noncompensatory Shoulder Movements Used for Reaching in StrokeMindy F Levin, Dario G Liebermann, Yisrael Parmet, et al.
Marine Pollution Bulletin|January 23, 2025
Boat noise reduces vocalization rate and alters vocal characteristics in wild plainfin midshipman fishMackenzie B Woods, William D Halliday, Sigal Balshine, et al.
Journal of Medical Internet Research|May 28, 2021
Detecting Impending Stroke From Cognitive Traits Evident in Internet Searches: Analysis of Archival DataSigal Shaklai, Ran Gilad-Bachrach, Elad Yom-Tov, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 11, 2022
Reduced exercise-induced growth hormone secretion among children with attention-deficit hyperactivity disorderDan Nemet, Sigal Ben-Zaken, Roi A Eliakim, et al.
Lancet (London, England)|April 25, 2003
Frequency of Down's syndrome and neural-tube defects in the same familyGad Barkai, Svetlana Arbuzova, Michal Berkenstadt, et al.
The EMBO Journal|December 8, 2021
Bacteria elicit a phage tolerance response subsequent to infection of their neighborsElhanan Tzipilevich, Osher Pollak-Fiyaksel, Bushra Shraiteh, et al.
Global Implementation Research and Applications|September 15, 2022
Predicting a Rapid Transition to Telehealth-Delivered Parent-Child Interaction Therapy Amid COVID-19: A Mixed Methods StudyYessica Green Rosas, Marika Sigal, Alayna Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1Batya Barkan, Sigal Starinsky, Eitan Friedman, et al.
Current Psychology (New Brunswick, N.J.)|July 12, 2021
Risk and protective factors for psychological distress during COVID-19 in IsraelZohar Oryan, Asia Avinir, Sigal Levy, et al.
International Immunology|October 21, 2003
Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cellsAlon Margalit, Sigal Fishman, Dikla Berko, et al.
Pageof 371